Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Invega Sustenna (paliperidone palmitate) 39mg, 78mg, 117mg, 156mg, and 234mg Extended-Release Injectable Suspension
Company: Ortho-McNeil-Jansen Pharmaceuticals, Inc.
Application No.: 022264
Approval Date: 7/31/2009

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.


Date created: May 13, 2010

Back to Top    Drugs@FDA

Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance.

Note: Documents in PDF format require the Adobe Acrobat Reader®.